A comparative study of Ayurveda drugs in the management of vicharchika

â??A Physiological Study of Twak With Special Reference To Role of Khadir Paan And Khadir Lepa in Vicharchikaâ??

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043336

Enrollment

Registered

2022-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects willing to undergo trial and ready to sign informed Consent. 2.Subjects with the classical signs and symptoms of Vicharchika, 3.Subjects of either sex aged between 18 - 60 years.

Exclusion criteria

Exclusion criteria: 1.The Subjects suffering from any other skin or systemic illness. 2.The pregnant women and lactating mother will be excluded.

Design outcomes

Primary

Measure	Time frame
Decrease in the grade of EASI score of Eczema.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Improvement in classical signs and symptoms of Vicharchika.Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Ajmal Hussain

National Institute of Ayurveda Deemed to be University Jaipur

ysarika19@gmail.com9467451607

Outcome results